Heart Failure Clinical Trial
Correlation of SOZO BIS Measures With CardioMEMS PA Pressure
Summary
This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured using the CardioMEMS HF System (St. Jude Medical).
Full Description
This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMSâ„¢ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll thirty participants. Participants will be monitored daily at home for a period of 30 days. Each day, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMSâ„¢ and the ImpediMed's BIS technology. Participant's weight will also be taken each day.
Eligibility Criteria
Inclusion Criteria:
Age 18 years or older.
NYHA Class III HF.
Patient has undergone implantation of CardioMEMS HF System (St. Jude Medical).
Patient is characterized by at least one of the following:
CardioMEMS implanted within the previous 90 days
Received treatment with intravenous diuretics within the previous 30 days
Received dose escalation of oral diuretics at least twice within the previous 30 days
Patient is able to sit upright for BIS measurements.
Patient provides written informed consent and authorization to use and disclose health information.
Exclusion Criteria:
Patient is enrolled in a concurrent interventional study of an experimental treatment that may confound the results of this study, in the investigator's opinion.
Patient has a clinical condition that would not allow them to complete the study.
Patient is pregnant or lactating.
Patient has nephrotic syndrome or nephrosis.
Patient has estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2 or end-stage renal disease requiring chronic dialysis.
Patient has been diagnosed with lymphedema.
Patient has chronic liver failure or cirrhosis.
Patient has a moderate or large pleural effusion as seen on chest X-ray.
Patient has been diagnosed with thrombophlebitis or deep vein thrombosis in arms or legs in the past 90 days.
Patient has an implanted cardiac rhythm management device (pacemaker or implantable cardioverter defibrillator).
Patient has an amputation of a limb.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Rochester Minnesota, 55905, United States
Lancaster Pennsylvania, 17603, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.